Clinical Trial Update: Efficacy Study of Pioglitazone and Atorvastatin Combination Therapy in Treating Subjects With Elevated Risk for Cardiovascular Disease [Phase 2]

View source ↗

Summary

Phase 2 efficacy study evaluating the combination of pioglitazone and atorvastatin in individuals at elevated risk for cardiovascular disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Takeda | Conditions: Cardiovascular Diseases | Phase 2 | Status: COMPLETED